1 Marrow relapse is the major obstacle to
cure for 10-15% of young patients with acute lymphoblast
2 At 120 degrees C, the strength of composite
cured for 10 min was 178 +/- 17, lower than 236 +/- 14 o
3 cobacteria in vitro than patients who remain
cured for 2 years.
4 8 +/- 17, lower than 236 +/- 14 of composite
cured for 3 hrs.
5 The proportion
cured for 3-mo regimens containing rifampicin or rifapen
6 , we leverage a unique dataset of 3,655 folk
cures for 35 diseases, collected in 1937/8 from a mostly
7 lant achieved remission and a possible HIV-1
cure for a person of diverse ancestry, living with HIV-1
8 al treatment might result in a new chance of
cure for a selected subgroup of patients.
9 we describe in one affected dog a functional
cure for a severe erythroid disease using stem cell sele
10 beta cell transplantation offers a potential
cure for a subset of diabetic patients.
11 stem cell transplantation (allo-SCT) offers
cure for a variety of conditions, in particular, but not
12 rrow transplantation (BMT) is the only known
cure for a variety of inherited diseases and requires th
13 nticipate long-term survival, and possibly a
cure, for a significant fraction of CNS lymphoma patient
14 n trials remains a major hurdle in advancing
cures for a number of otherwise incurable diseases.
15 Base editing offers a potential
cure for A1AT; however, effective treatment is hindered
16 There is currently no
cure for AD and no reliable method of diagnosis other th
17 Despite considerable research efforts, a
cure for AD remains elusive, with current therapies prim
18 s scientific progress, there is no effective
cure for AD.
19 s the deadliest form of skin cancer, with no
cure for advanced disease.
20 ntially offer amelioration--and perhaps even
cure--for afflicted individuals.
21 ells that constitutes the major barrier to a
cure for AIDS is exquisitely redox sensitive and could b
22 uld be induced in humans, it could provide a
cure for AIDS.
23 istence is therefore the major obstacle to a
cure for AIDS.
24 are targeted to lead to viral eradication--a
cure for AIDS.
25 l potential of rAAV-CFTRDeltaR in offering a
cure for all patients with CF in the future.
26 correction presents one of few options for a
cure for all patients with cystic fibrosis.
27 In co-endemic regions, universal radical
cure for all patients with uncomplicated malaria has the
28 to assess the potential benefits of radical
cure for all patients with uncomplicated malaria in co-e
29 drug discovery strives to move away from one-
cure-for-
all and makes use of the various targets and bi
30 ocus may enable the development of a durable
cure for almost all CF patients, irrespective of the cau
31 Currently there is no
cure for AMD, but several treatment options have started
32 Currently, there is no
cure for asthma, only symptomatic treatment.
33 Unfortunately, there is no
cure for asthma.
34 Because there is no
cure for autoimmunity, it is extremely important to stud
35 studies that are directed towards finding a
cure for beta-thalassaemia using vorinostat.
36 otion of crude shark cartilage extracts as a
cure for cancer has contributed to at least two signific
37 s skin cancer or that the alkaline diet is a
cure for cancer, even with jailbreaking attempts.
38 ity and remains a hurdle in the search for a
cure for cancer.
39 relapse are major obstacles in identifying a
cure for cancer.
40 ver the last few decades in the search for a
cure for cancer.
41 te relapse causing dormant cells and offer a
cure for cancer.
42 on the continuing struggle to find effective
cures for cancer.
43 Finding a
cure for cardiovascular disease remains a major unmet me
44 e good outcomes overall, the likelihood of a
cure for certain sites and histologic conditions is less
45 A
cure for CHC was associated with an MRR of 0.64 (95% CI,
46 e to oral chemotherapy regimens in attaining
cure for children with acute lymphoblastic leukemia (ALL
47 prognostic for outcome, but did not prevent
cure for children with acute lymphoblastic leukemia (ALL
48 hereby advancing efforts toward a functional
cure for chronic HBV infections.
49 Effective therapies leading to a functional
cure for chronic hepatitis B are still lacking.
50 Although there is no effective
cure for chronic hepatitis B virus (HBV) infection, anti
51 There is no definite
cure for chronic hepatitis B, and alpha interferon (IFN-
52 dedicated to accelerating the discovery of a
cure for chronic hepatitis B.
53 A "
cure" for chronic hepatitis C remains elusive.
54 addressed before these therapies can provide
cures for chronic conditions and rare diseases, rather t
55 inues to serve as a platform of "operational
cure" for CML with TKIs and immunotherapies.
56 tion offers a precise diagnosis, there is no
cure for CMT at present.
57 but has fallen short of delivering effective
cures for complex human diseases with complicated causes
58 e project has sparked hope and optimism that
cures for debilitating conditions can be achieved and ta
59 Given the lack of
cure for dementia, identifying modifiable risk factors i
60 Light cure is a popular mode of
curing for dental adhesives.
61 ide reasons for optimism in the search for a
cure for devastating autoimmune diseases.
62 Two promising approaches toward a cell-based
cure for diabetes are the directed differentiation of pl
63 islet transplantation has raised hopes for a
cure for diabetes mellitus, especially in patients with
64 Here, we describe a potential
cure for diabetes using a cellular therapy to ameliorate
65 xpansion of autoreactive T cells; however, a
cure for diabetes would require tolerance to be establis
66 -producing cells in vitro could constitute a
cure for diabetes, recent studies have explored the mole
67 With the ultimate hope of finding a
cure for diabetes, researches are looking into altering
68 Islet transplantation is a promising
cure for diabetes.
69 The composites were light-
cured for different time periods (9 s, 12 s, 25 s, 40 s,
70 caffolds in tissue engineering or developing
cures for diseases associated with protein fibers.
71 To find
cures for diseases like breast cancer that rely on epith
72 optimal primary preventions, treatments and
cures for diseases.
73 velopment of safe, permanent, and functional
cures for diverse genetic and nongenetic diseases.
74 There is currently no
cure for DMD although various promising approaches are p
75 There is no
cure for DMD and current therapeutic approaches to resto
76 To date, there is no effective
cure for DMD, and the identification of novel molecular
77 onset of pathology might convey a long-term
cure for DMD.
78 Currently there is no
cure for DMD.
79 The search for a
cure for Duchenne muscular dystrophy and other muscular
80 A
cure for dystrophin-deficient muscular dystrophy require
81 etween NV1023 and NV1042, with five of seven
cures for each virus.
82 herapy is associated with the best chance of
cure for EGCTs.
83 Transplantation is a
cure for end-stage organ failure but, in the absence of
84 Transplantation is the only
cure for end-stage organ failure, but without immunosupp
85 There is no
cure for endometriosis.
86 urrently, there is no effective treatment or
cure for epidermolysis bullosa, but bone marrow transpla
87 roject of the Epilepsy Foundation, Finding A
Cure for Epilepsy and Seizures.
88 ments could further aid in the path toward a
cure for ERBB2-positive MBC.
89 's diversity currently thwarts our goal of a
cure for every patient, but recent integration of genomi
90 The only proven
cure for Fanconi anemia (FA)-associated bone marrow fail
91 Achieving a
cure for FL will require targeted therapies that selecti
92 Until a
cure for FMS is found, CAM providers may offer an econom
93 However, a
cure for food allergy has not yet been achieved and pati
94 ptoms of disease, but currently, there is no
cure for food allergy.
95 There is currently no
cure for fragile X, although medications targeting speci
96 While there is no definitive
cure for FXS, the understanding of FMRP function has pav
97 zed biomedical research and offers potential
cures for genetic diseases.
98 and the murine model (Twitcher), there is no
cure for GLD.
99 require life-long treatment and there is no
cure for HBV infection.
100 n (HDF), dedicated to finding treatments and
cures for HD.
101 ic cell transplantation (HCT) is a potential
cure for hematologic cancer but is associated with a ris
102 Gene therapy may provide a
cure for hemophilia and overcome the limitations of prot
103 eption of liver transplantation, there is no
cure for hemophilia, which is currently managed by preem
104 came to our institution seeking a miracle-a
cure for his incurable cancer.
105 Current efforts toward achieving a
cure for HIV are focused on developing strategies to eli
106 research towards achievment of a functional
cure for HIV in neonates, including difficult trade-offs
107 The search for a
cure for HIV infection has highlighted the need for incr
108 The major obstacle to a
cure for HIV infection is the persistence of replication
109 Achievement of a
cure for HIV infection might need reactivation of latent
110 search has been energized by prospects for a
cure for HIV infection or, at least, for a "functional c
111 search efforts are now underway to develop a
cure for HIV infection, allowing patients to discontinue
112 lls are the greatest obstacle to obtaining a
cure for HIV infection, as these cells can persist despi
113 Second, scientists are trying to develop a
cure for HIV infection, which would alleviate the need f
114 ding HIV latency that might lead to a future
cure for HIV infection.
115 oved viral control and possibly a functional
cure for HIV infection.
116 e effective, antiretroviral therapy is not a
cure for HIV infection.
117 V, there is intense interest in developing a
cure for HIV infection.
118 Developing a
cure for HIV is a global priority.
119 A sterilizing or functional
cure for HIV is currently precluded by resting CD4(+) T
120 ABTRACT: Establishing a
cure for HIV is hindered by the persistence of latently
121 A
cure for HIV is still greatly needed and has become a gl
122 The quest for a
cure for HIV remains a timely and key challenge for the
123 een captured by the possibility of finding a
cure for HIV transmitted from mother to child.
124 will not lead to a functional or sterilizing
cure for HIV(+) patients.
125 To get a
cure for HIV, it is important to identify and characteri
126 rollers may serve as a model of a functional
cure for HIV-1 but the mechanisms responsible for viral
127 istic picture of what a generally applicable
cure for HIV-1 infection is likely to entail.
128 dividual, have renewed interest in finding a
cure for HIV-1 infection.
129 d progenitor cells (HSPCs) is the only known
cure for HIV-1 infection.
130 ent a major obstacle to finding a functional
cure for HIV-1 infection.
131 mulation as a strategy aimed at a functional
cure for HIV-1 infection.
132 PORTANCE A reason that there is no universal
cure for HIV-1 is that the virus can hide in the genome
133 A
cure for HIV-1 remains unattainable as only one case has
134 V-1) in many patients, currently there is no
cure for HIV-1, presumably due to the presence of reserv
135 viral therapy (ART) is critical to finding a
cure for HIV-1.
136 f the immune system may eventually lead to a
cure for HIV-infected patients.
137 Such intervention might possibly lead to a
cure for HIV-infected patients.
138 id in the development of strategies toward a
cure for HIV.
139 Proviral latency is a major barrier to a
cure for HIV.
140 es represent major obstacles to a definitive
cure for HIV.
141 servoirs is a major challenge in achieving a
cure for HIV.
142 ategies to eradicate or develop a functional
cure for HIV.
143 Given the difficulty in finding a
cure for HIV/AIDS, a promising prevention strategy to re
144 development of novel therapies and potential
cures for HIV infection.
145 ven the renewed effort to identify potential
cures for HIV.
146 As there is no
cure for HLB, insect vector management is considered one
147 The clinical cure rate at test-of-
cure for hospital-acquired cIAI was higher with moxiflox
148 ikely possible, and may offer a pathway to a
cure for HSV infection.
149 A major challenge in the development of a
cure for human immunodeficiency virus (HIV) has been the
150 Research toward a
cure for human immunodeficiency virus type 1 (HIV-1) inf
151 vast potential of the oceans to lead to new
cures for human and animal disease; the exploitation of
152 Although there is no
cure for idiopathic pulmonary arterial hypertension, rec
153 To estimate chance of
cure for individual patients, a nomogram was developed,
154 lting in life-long immunity, but there is no
cure for individuals with chronic HBV infection, which t
155 biology holds future promise for developing
cures for infectious diseases, cancer, and autoimmune di
156 dustrialized world, and to date, there is no
cure for it despite extensive research and numerous clin
157 ent there is no disease modifying therapy or
cure for it; and management of the disease is limited to
158 m remains unclear, and there is currently no
cure for KS.
159 be administered in the clinic (ie, a "1-shot
cure" for latent TB).
160 There is no
cure for Leigh syndrome; therefore, new therapeutic targ
161 There is no
cure for LEMS, and the current most commonly used sympto
162 There is no effective
cure for LOAD, leaving the treatment efforts to depend o
163 lete surgical resection offers the chance of
cure for localized gastric cancer.
164 Identifying
cures for long-term problems of a complex developmental
165 At present, there are no
cures for LSDs and the available treatments are generall
166 ion doxycycline + azithromycin achieved high
cure for macrolide-susceptible infections.
167 With no
cure for malignant pleural effusion, efforts are focused
168 elopment of new diagnostics, treatments, and
cure for many diseases.
169 ome editing holds the promise of a potential
cure for many genetic diseases, including TNBC; however,
170 The major impediment to
cure for many malignancies is the development of therapy
171 s has improved clinical outcomes and offered
cures for many affected individuals living in high-incom
172 ere are currently no effective treatments or
cures for MDC1A.
173 ts to treat MDS; however, the only potential
cure for MDS remains stem cell transplantation.
174 e fatalities; however, there is no effective
cure for men with advanced disease and additional therap
175 At present, no
cure for metastatic prostate cancer exists, as targeting
176 Currently, there is no
cure for mitochondrial disorders.
177 ic stem cell (HSC) transplantation, the only
cure for most hematopoietic diseases.
178 common inherited anemias, with no effective
cure for most patients.
179 There is no
cure for MS, but available disease-modifying therapies c
180 onstrate the ability to produce a phenotypic
cure for murine SCD using a nonmyeloablative protocol wi
181 Progress toward finding a
cure for muscle diseases has been slow because of the ab
182 d gene therapy research raise the hope for a
cure for muscular dystrophy in the near future.
183 he only therapeutic modality that provides a
cure for myelofibrosis patients.
184 There are no
cures for neurodegenerative diseases and this is partial
185 g therapies under investigation, there is no
cure for NM.
186 ne marrow transplantation (BMT) represents a
cure for nonmalignant hematological disorders.
187 le to that achieved by Portland cement after
curing for only 2 days.
188 There is no
cure for or licensed vaccine against CHIKV infection.
189 METHODS AND FINDINGS: The
cures for osteoporosis are limited, consequently the pot
190 There is no
cure for PAH, despite effective treatments, and outcomes
191 l resection provides the only possibility of
cure for pancreas cancer.
192 iral (DAA) therapy has led to near-universal
cure for patients chronically infected with hepatitis C
193 rd improved quality of life and eventually a
cure for patients suffering from EB, a currently intract
194 ne therapy may present a treatment but not a
cure for patients who have already experienced vision lo
195 rucial intervention and provides a chance of
cure for patients with cancer.
196 etic cell transplantation may offer the only
cure for patients with hematological diseases.
197 that target causes and ultimately provide a
cure for patients with irritable bowel syndrome.
198 Although surgery offers the best chance of
cure for patients with non-small cell lung cancer (NSCLC
199 In addition to providing a potential
cure for patients with pyruvate kinase deficiency, in vi
200 There is no
cure for patients with stage IV NSCLC.
201 emporary to chronic control of disease, or a
cure, for patients with advanced-stage solid cancers.
202 on remain unclear, and currently there is no
cure for PD, only symptomatic treatments.
203 gation aimed at exploring the prospects of a
cure for persistent medullary thyroid cancer (MTC) strat
204 om bone marrow transplantation, a definitive
cure for Philadelphia (Ph) chromosome-positive chronic m
205 Bone marrow transplantation remains the only
cure for PNH but should be reserved for patients with su
206 nal hypertension and seizures, but the only '
cure' for pre-eclampsia is delivery of the dysfunctional
207 Currently, delivery is the only
cure for preeclampsia; therefore, effective prevention a
208 that rescues TorsinADeltaE could serve as a
cure for primary dystonia.
209 A
cure for prostate cancer (CaP) will be possible only aft
210 Currently no
cure for psoriasis is available due to limited knowledge
211 There are no causal
cures for psychiatric disorders and available therapies
212 FMT is a highly effective
cure for RCDI, but increased knowledge of the intestinal
213 Until recently, the only
cure for relapse after allogeneic bone marrow transplant
214 Gene transfer therapy is the most promising
cure for retinal dystrophies and has primarily been appl
215 Current approaches offer no
cures for rheumatoid arthritis (RA).
216 A hypothetical cell or gene therapy
cure for SCD is likely to be cost-effective from the US
217 (HSC) transplantation allows for a one-time
cure for SCD, albeit with histocompatibility limitations
218 s one of the primary targets in developing a
cure for SCI.
219 At present, there are no "
cures" for secondary metastatic cancer of any form and t
220 Cerebral hemispherectomy remains the only
cure for seizures, but there are inevitable functional c
221 Our report suggests some hope of
cure for selected patients with severe forms of this dis
222 ion with reduced-intensity conditioning is a
cure for several nonmalignant hematologic disorders that
223 Gene therapy as a potential
cure for sickle cell disease (SCD) has long been pursued
224 etic stem cell transplant (HSCT) is the only
cure for sickle cell disease (SCD).
225 Currently, there is no
cure for Sjogren's syndrome, and treatment is mainly pal
226 Since there is no effective
cure for SMA presently, prevention through the identific
227 le drugs is variable; a drug that provides a
cure for some may confer no therapeutic benefit or trigg
228 ars from discontinuation provides hope for a
cure for some patients.
229 th acute myeloid leukemia (AML) and provided
cure for some.
230 Because there is no
cure for SRS, treatment plans focus on alleviating sympt
231 ightforward and simple solution to provide a
cure for T1D is immensely attractive but entails at leas
232 ans for truly identifying the cause of and a
cure for T1D.
233 ver, there is still no universally available
cure for thalassemias.
234 critical first step toward development of a
cure for the 400 million patients who are chronically in
235 There is no
cure for the advanced disease.
236 nes into autologous stem cells and provide a
cure for the BM failure in FA patients.
237 nes into autologous stem cells and provide a
cure for the BM failure in FA patients.
238 The rates of hospital mortality and clinical
cure for the continuous versus intermittent infusion gro
239 ften encountered; thus, there is no complete
cure for the disease or its symptoms.
240 Currently, there is no
cure for the disease which is in part due to the heterog
241 Liver transplantation offers the only
cure for the genetic defect causing FAP and appears to r
242 rrow transplantation (BMT) is the only known
cure for the hematologic manifestations of Fanconi anemi
243 at current standard therapy does not lead to
cure for the majority of patients with B-cell malignanci
244 eatment durations may be possible to achieve
cure for the majority of patients with M/XDR-TB.
245 iptionally dormant cells currently thwarts a
cure for the more than 35 million individuals infected w
246 d bone marrow transplantation as a potential
cure for the syndrome, which is usually lethal within th
247 to prescribing primaquine (PQ)-based radical
cure for the treatment of vivax malaria.
248 e of type 1 diabetes (T1D) and developing a "
cure" for the disease.
249 f biologic systems and on the development of
cures for the latter.
250 al connections needed for the development of
cures for the most common and devastating diseases invol
251 A strict gluten-free diet is the sole
cure for these ailments.
252 is of these cancers but also the hope of the
cure for these cancers.
253 experience, looking ahead to the chance of a
cure for these disorders.
254 Given the lack of rapid
cures for these infections and the limitations of curren
255 ly, gene therapy may be possible, leading to
cures for these sight-threatening diseases.
256 or a complete understanding of, and eventual
cure for,
these childhood epilepsy syndromes.
257 nd manage AD patients, and perhaps to find a
cure for this chronic condition.
258 nerstones of the successful development of a
cure for this chronic disease.
259 Currently, there is no
cure for this condition but treatments for general obesi
260 A permanent
cure for this condition can be achieved by closing the p
261 There has been no
cure for this condition, but replacement of deficient he
262 earch for a genuinely effective treatment or
cure for this dementia.
263 ire an intense research focus as we pursue a
cure for this devastating disease.
264 thways may lead to effective therapies and a
cure for this devastating disease.
265 model opens new opportunities for finding a
cure for this devastating neurodegenerative disease.
266 ursors suggest that cell therapy may offer a
cure for this devastating neurological disease.
267 There is no
cure for this disease and current treatment modalities f
268 Still there is no
cure for this disease and more promising treatments are
269 tested in clinical trials, there is still no
cure for this disease, although several proposed treatme
270 Unfortunately, there is no
cure for this disease, which highlights the need for fur
271 cell transplantation (SCT) is the only known
cure for this disease.
272 S there is still no effective vaccine and no
cure for this disease.
273 er, to apoptosis is the key for developing a
cure for this disease.
274 of worm genetics to bear on the search for a
cure for this disease; work on this worm has already led
275 There is currently no
cure for this disorder.
276 There is no complete
cure for this heterogeneous group of diseases, but a sen
277 ce to this agent mitigates the prospect of a
cure for this leukemia.
278 As yet, there is no
cure for this neuromuscular disorder which affects the l
279 elling results suggesting that the path to a
cure for this rare orphan disease might be heading in a
280 tive catheter ablation will be as a longterm
cure for this type of VT.
281 kin warts, has shown potential as a possible
cure for this virus related lesions.
282 There is no
cure for this, partly because cavities and scar tissue f
283 t, and as yet unsolved, challenge to develop
cures for this disease.
284 There is no
cure for tics, and symptomatic therapy includes behavior
285 ic iliac lymphadenectomy, with the intent to
cure, for transitional-cell carcinoma of the bladder bet
286 ess in cancer treatment in recent years, the
cure for triple-negative breast cancer (TNBC) remains el
287 h as radiofrequency ablation offer potential
cure for tumors detected at an early stage in well selec
288 dio frequency ablation offer the chance of a
cure for tumors detected at an early stage in well selec
289 A logical
cure for type 1 diabetes (T1D) involves replacing the lo
290 let transplantation is a promising potential
cure for type 1 diabetes (T1D).
291 There is yet no
cure for type 1 diabetes (T1DM) so far.
292 l in facilitating islet transplantation as a
cure for type 1 diabetes mellitus.
293 f pancreatic islet transplantation (Tx) as a
cure for type 1 diabetes remains limited.
294 A
cure for type 1 diabetes will probably require the provi
295 Islet transplantation represents a potential
cure for type 1 diabetes, yet persistent autoimmune and
296 orldwide epidemic of type 2 diabetes and the
cure for type 1 diabetes.
297 Although there is no known
cure for Type 2 diabetes, early diagnosis and interventi
298 Islet transplantation provides a "
cure" for type 1 diabetes but is limited in part by recu
299 Extensive research has resulted in no
cure for what is perceived as the most common dementing
300 g novel treatment strategies and achieving a
cure for Wolfram-syndrome-spectrum disorder.